Wilms Tumor and the WT1 Gene
- 1 March 2001
- journal article
- review article
- Published by Elsevier in Experimental Cell Research
- Vol. 264 (1) , 74-99
- https://doi.org/10.1006/excr.2000.5131
Abstract
No abstract availableKeywords
This publication has 199 references indexed in Scilit:
- Wilms' Tumor Gene Product WT1 Arrests Macrophage Differentiation of HL-60 Cells Through Its Zinc-Finger DomainBiochemical and Biophysical Research Communications, 1999
- Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlates with clinicopathological parametersGenes, Chromosomes and Cancer, 1998
- The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic propertiesOncogene, 1998
- The DNA binding domains of the WT1 tumor suppressor gene product and chimeric EWS/WT1 oncoprotein are functionally distinctOncogene, 1998
- The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumourNature Genetics, 1997
- Two N-Terminal Self-Association Domains Are Required for the Dominant Negative Transcriptional Activity of WT1 Denys-Drash Mutant ProteinsBiochemical and Biophysical Research Communications, 1997
- Tumour-suppressor activity of H19 RNANature, 1993
- Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumourNature, 1993
- Epithelial-mesenchymal interactions regulate the stage-specific expression of a cell surface proteoglycan, syndecan, in the developing kidneyDevelopmental Biology, 1989
- Abnormality of chromosome 11 in patients withfeatures of Beckwith-Wiedemann syndromeThe Journal of Pediatrics, 1983